{"title":"Blends","description":"Pre-formulated research peptide blends combining complementary compounds for streamlined laboratory workflows. Includes the Wolverine Blend, KLOW Blend, IPA\/CJC Blend, and Recovery formulations. For research use only.","products":[{"product_id":"wolverine-blend","title":"Wolverine Blend","description":"\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp dir=\"auto\" style=\"white-space: pre-wrap;\"\u003e\u003cstrong\u003eWolverine Blend\u003c\/strong\u003e (also known as the \u003cstrong\u003eWolverine Stack\u003c\/strong\u003e or \u003cstrong\u003eBPC-157\/TB-500 Blend\u003c\/strong\u003e) is a \u003cstrong\u003esynthetic peptide combination\u003c\/strong\u003e consisting of \u003cstrong\u003eBPC-157\u003c\/strong\u003e (Body Protection Compound-157) and \u003cstrong\u003eTB-500\u003c\/strong\u003e (Thymosin Beta-4), typically formulated in a single vial (e.g., 10mg BPC-157 + 10mg TB-500 or similar ratios). This research formulation has gained significant attention in preclinical and regenerative medicine investigations for its synergistic potential to accelerate tissue repair, reduce inflammation, and support recovery processes. The nickname \"Wolverine\" draws from the Marvel character's rapid healing abilities, reflecting the observed complementary actions of the two peptides in animal models. Preliminary and advanced preclinical studies on the individual components and their combination suggest enhanced effects on angiogenesis, cell migration, extracellular matrix remodeling, and anti-inflammatory pathways. Researchers utilize Wolverine Blend in laboratory and animal models to explore mechanisms of musculoskeletal, soft tissue, and systemic regeneration, particularly in injury, overuse, and age-related degeneration contexts. As a research-grade compound, Wolverine Blend is intended exclusively for in vitro and animal studies. Scientists value its combined profile, which may offer broader regenerative coverage than either peptide alone, providing insights into multi-pathway peptide synergy in tissue restoration.\u003c\/p\u003e\n\u003ch3 dir=\"auto\"\u003eKey Research Applications\u003c\/h3\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eMusculoskeletal and Soft Tissue Regeneration\u003c\/strong\u003e — Preclinical models demonstrate that the BPC-157\/TB-500 combination markedly accelerates healing of muscles, tendons, ligaments, and joints. It enhances biomechanical recovery, collagen organization, and structural integrity in transection, crush, and overuse injury models, often showing superior outcomes compared to single-peptide administration.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eInjury Recovery and Wound Healing\u003c\/strong\u003e — Investigations highlight accelerated closure of cutaneous, surgical, and deep-tissue wounds, with reduced scar formation and improved granulation tissue quality. The blend supports re-epithelialization, cell proliferation, and resolution of inflammation in various trauma and post-surgical paradigms.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnti-Inflammatory and Cytoprotective Effects\u003c\/strong\u003e — The combination potently downregulates pro-inflammatory cytokines, mitigates oxidative stress, and promotes a reparative microenvironment. Studies explore its efficacy in models of chronic inflammation, tendonitis, arthritis, and systemic inflammatory insults.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAngiogenesis and Vascular Support\u003c\/strong\u003e — Synergistic activation of VEGF pathways, endothelial cell migration, and new vessel formation facilitates nutrient delivery and oxygenation in ischemic or poorly vascularized tissues, enhancing overall regenerative potential.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBroader Systemic and Protective Effects\u003c\/strong\u003e — Research suggests benefits in gastrointestinal protection (from BPC-157's gastric origin), cardiac tissue support, and general recovery from physical stress. Emerging data probe its role in age-related decline, overuse syndromes, and multi-tissue repair scenarios.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 dir=\"auto\"\u003eTechnical Specifications\u003c\/h3\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eComposition\u003c\/strong\u003e: Blend of BPC-157 (C₆₂H₉₈N₁₆O₂₂; MW 1419.5 g\/mol), TB-500 (C₂₁₂H₃₅₀N₅₆O₇₈S; MW 4963.5 g\/mol).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Weight\u003c\/strong\u003e: Composite (varies by exact ratio; typically ~6,383 g\/mol for equal parts).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequences\u003c\/strong\u003e:\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003eBPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val\u003c\/li\u003e\n\u003cli\u003eTB-500: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e","brand":"Omni Peptides","offers":[{"title":"10 mg (5+5)","offer_id":50500493410551,"sku":"WOL10","price":400.0,"currency_code":"AED","in_stock":true},{"title":"20 mg (10+10)","offer_id":50500493443319,"sku":"WOL20","price":760.0,"currency_code":"AED","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0918\/6777\/5223\/files\/wol_20mg.png?v=1771307940"},{"product_id":"klow-blend","title":"KLOW Blend","description":"\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp dir=\"auto\" style=\"white-space: pre-wrap;\"\u003e\u003cstrong\u003eKLOW Blend\u003c\/strong\u003e (also known as \u003cstrong\u003eKlow Stack\u003c\/strong\u003e or \u003cstrong\u003eRadiance Recovery Blend\u003c\/strong\u003e) is a \u003cstrong\u003esynthetic multi-peptide formulation\u003c\/strong\u003e combining \u003cstrong\u003eBPC-157\u003c\/strong\u003e, \u003cstrong\u003eTB-500\u003c\/strong\u003e (Thymosin Beta-4), \u003cstrong\u003eKPV\u003c\/strong\u003e, and \u003cstrong\u003eGHK-Cu\u003c\/strong\u003e in a single lyophilized vial (commonly totaling 80 mg, with typical ratios such as BPC-157 10 mg, TB-500 10 mg, KPV 10 mg, GHK-Cu 50 mg). This research blend has garnered significant attention in preclinical regenerative studies for its synergistic potential to address tissue repair, inflammation resolution, immune modulation, and extracellular matrix remodeling through complementary pathways. It builds on simpler blends like Wolverine (BPC-157 + TB-500) by incorporating KPV for enhanced anti-inflammatory effects and GHK-Cu for collagen synthesis and dermal\/tissue rejuvenation. Researchers employ KLOW Blend in laboratory and animal models to investigate multi-target regenerative mechanisms, particularly in injury recovery, chronic inflammation, wound healing, and age-related tissue decline. As a research-grade compound, KLOW Blend is intended exclusively for in vitro and animal studies. Scientists value its broad-spectrum approach, combining cytoprotective, angiogenic, actin-regulatory, and copper-mediated signaling for comprehensive tissue restoration research.\u003c\/p\u003e\n\u003ch3 dir=\"auto\"\u003eKey Research Applications\u003c\/h3\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eComprehensive Tissue and Musculoskeletal Regeneration\u003c\/strong\u003e — Preclinical models show the blend accelerates repair of muscles, tendons, ligaments, skin, and connective tissues. BPC-157 and TB-500 drive angiogenesis and cell migration, while GHK-Cu supports collagen deposition and matrix remodeling, often yielding enhanced biomechanical recovery in injury and overuse paradigms.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnti-Inflammatory and Immune Modulation\u003c\/strong\u003e — KPV potently suppresses pro-inflammatory cytokines (e.g., TNF-α, IL-6) and NF-κB signaling, complementing the cytoprotective and resolution-promoting actions of the other components. Studies explore efficacy in models of chronic inflammation, autoimmune-like conditions, gastrointestinal insults, and systemic inflammatory states.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWound Healing and Dermal Repair\u003c\/strong\u003e — The combination promotes re-epithelialization, granulation tissue formation, reduced scarring, and improved collagen organization. GHK-Cu's role in extracellular matrix synthesis synergizes with TB-500's cell motility and BPC-157's growth factor modulation, making it a focus in cutaneous, surgical, and chronic wound models.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSystemic Recovery and Anti-Aging Effects\u003c\/strong\u003e — Investigations highlight benefits in metabolic support, oxidative stress reduction, mitochondrial function preservation, and overall tissue resilience. The blend is studied for potential in age-related decline, post-exercise recovery, and multi-organ protection (e.g., gut, skin, musculoskeletal).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSynergistic Multi-Pathway Mechanisms\u003c\/strong\u003e — Research examines how the four peptides interact to amplify regenerative outcomes beyond individual administration, including enhanced VEGF pathways, actin dynamics, copper-dependent enzyme activity, and melanocortin-mediated inflammation control.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 dir=\"auto\"\u003eTechnical Specifications\u003c\/h3\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eComposition\u003c\/strong\u003e: Blend of BPC-157 (C₆₂H₉₈N₁₆O₂₂; MW 1419.5 g\/mol), TB-500 (C₂₁₂H₃₅₀N₅₆O₇₈S; MW 4963.5 g\/mol), KPV (C₁₆H₃₀N₄O₄; MW 342.43 g\/mol), GHK-Cu (C₁₄H₂₂CuN₆O₄; MW 401.9 g\/mol).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Weight\u003c\/strong\u003e: Composite (varies by exact ratio; approximately 6,000–7,000 g\/mol for standard formulations).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequences\u003c\/strong\u003e:\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003eBPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val\u003c\/li\u003e\n\u003cli\u003eTB-500: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser\u003c\/li\u003e\n\u003cli\u003eKPV: Lys-Pro-Val\u003c\/li\u003e\n\u003cli\u003eGHK-Cu: Gly-His-Lys (complexed with Cu²⁺)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e","brand":"Omni Peptides","offers":[{"title":"Default Title","offer_id":50432797409527,"sku":"KLOW80","price":1150.0,"currency_code":"AED","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0918\/6777\/5223\/files\/klow_80mg.png?v=1771307398"},{"product_id":"cjc-ipa-blend","title":"IPA\/CJC Blend","description":"\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp dir=\"auto\" style=\"white-space: pre-wrap;\"\u003e\u003cstrong\u003eCJC-1295 No DAC + Ipamorelin\u003c\/strong\u003e (often called the \u003cstrong\u003e“Gold Standard” GH-releasing combo\u003c\/strong\u003e or \u003cstrong\u003eCJC\/Ipa blend\u003c\/strong\u003e) is a \u003cstrong\u003esynthetic peptide combination\u003c\/strong\u003e pairing \u003cstrong\u003eCJC-1295 without DAC\u003c\/strong\u003e (Modified GRF 1-29) with \u003cstrong\u003eIpamorelin\u003c\/strong\u003e, typically provided in a single lyophilized vial (common ratios include 5 mg CJC-1295 No DAC + 5 mg Ipamorelin, 2 mg\/2 mg, or 10 mg total blends). This research formulation has become one of the most widely studied and utilized growth hormone secretagogue stacks in preclinical models due to its potent synergistic stimulation of \u003cstrong\u003eendogenous pulsatile growth hormone\u003c\/strong\u003e (\u003cstrong\u003eGH\u003c\/strong\u003e) release while maintaining a remarkably clean side-effect profile. CJC-1295 No DAC acts as a GHRH analog to amplify GH pulse amplitude, while Ipamorelin functions as a selective ghrelin mimetic (GHS-R1a agonist) to increase pulse frequency and potency, resulting in supra-additive GH\/IGF-1 elevation. Researchers employ this blend in laboratory and animal models to investigate mechanisms of GH axis physiology, body composition optimization, tissue repair, metabolic regulation, and age-related endocrine decline. As a research-grade compound, CJC-1295 No DAC + Ipamorelin is intended exclusively for in vitro and animal studies. Scientists value its near-physiological pulsatile GH pattern, minimal impact on cortisol\/prolactin, lack of significant appetite stimulation, and exceptional synergy for studying maximal endogenous GH output without exogenous hormone administration.\u003c\/p\u003e\n\u003ch3 dir=\"auto\"\u003eKey Research Applications\u003c\/h3\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003e\n\u003cstrong\u003ePulsatile Growth Hormone and IGF-1 Amplification\u003c\/strong\u003e — Preclinical studies consistently demonstrate that the combination produces dramatically higher GH peaks and greater total GH\/IGF-1 area-under-the-curve compared to either peptide alone. The synergy mimics youthful, multi-pulse GH secretion patterns while preserving negative feedback regulation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBody Composition and Anabolic Research\u003c\/strong\u003e — The blend promotes increases in lean muscle mass, improved nitrogen retention, enhanced protein synthesis, and reductions in fat mass in various animal models. It is frequently investigated in sarcopenia, cachexia, muscle wasting, post-injury recovery, and age-related body composition decline.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFat Metabolism and Lipolysis\u003c\/strong\u003e — Research shows enhanced lipolytic activity, increased fatty acid oxidation, and preferential reduction in visceral and subcutaneous fat depots, often attributed to elevated GH pulses and improved metabolic flexibility without significant insulin resistance.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTissue Repair and Recovery\u003c\/strong\u003e — The combination accelerates healing of muscle, tendon, ligament, cartilage, and bone injuries in preclinical models. Studies explore benefits in wound healing, connective tissue regeneration, post-surgical recovery, and counteracting catabolic states through elevated GH\/IGF-1 axis activity.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnti-Aging and Metabolic Health\u003c\/strong\u003e — Investigations highlight potential improvements in insulin sensitivity (in certain dosing contexts), bone density, skin elasticity, sleep quality, and overall vitality markers. The clean profile makes it a favored tool for studying long-term GH restoration effects in aging and metabolic syndrome models.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 dir=\"auto\"\u003eTechnical Specifications\u003c\/h3\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eComposition\u003c\/strong\u003e: Blend of CJC-1295 No DAC (C₁₅₂H₂₅₂N₄₄O₄₂; MW 3367.9 g\/mol),  Ipamorelin (C₃₈H₄₉N₉O₅; MW 711.85 g\/mol).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Weight\u003c\/strong\u003e: Composite (~4,080 g\/mol for equal parts).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequences\u003c\/strong\u003e:\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003eCJC-1295 No DAC: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂ (C-terminal amidation; substitutions: D-Ala², Gln⁸, Ala¹⁵, Leu²⁷)\u003c\/li\u003e\n\u003cli\u003eIpamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH₂ (Aib = 2-aminoisobutyric acid; D-2-Nal = D-2-naphthylalanine; C-terminal amidation)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e","brand":"Omni Peptides","offers":[{"title":"10 mg (5+5)","offer_id":50436630872311,"sku":null,"price":400.0,"currency_code":"AED","in_stock":true},{"title":"18 mg (12+6)","offer_id":50436630905079,"sku":null,"price":600.0,"currency_code":"AED","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0918\/6777\/5223\/files\/ipa_cjc_10mg_38526b14-2f36-4f57-a044-9afa8b117429.png?v=1768806275"}],"url":"https:\/\/dubaipeptides.ae\/collections\/blends.oembed","provider":"Dubai Peptides","version":"1.0","type":"link"}